Integrated T Cell Activation: Soluble DynActivator CD3/CD28 Prototype

In cell therapy manufacturing, activation quality can make or break the final drug product. Underpowered activation translates directly to poor proliferation, diminished functionality, and shortened T cell longevity - outcomes no developer can afford.

The Gibco Soluble DynActivator CD3/CD28 Prototype reframes what activation can look like: a bead-free, soluble format that decouples activation from isolation steps and integrates cleanly into existing workflows. A single vial handles up to 1.5 billion T cells, and removal requires nothing more than a standard cell wash. Early data shows strong CD25 and CD69 expression by day 2 and robust expansion through day 9. Download the brochure to explore how this approach could fit your workflow.